Faculty Opinions recommendation of Novel treatment approaches for refractory anxiety disorders.

Author(s):  
Malcolm Lader
2008 ◽  
Vol 6 (4) ◽  
pp. 486-495 ◽  
Author(s):  
Mark H. Pollack ◽  
Michael W. Otto ◽  
Peter P. Roy-Byrne ◽  
Jeremy D. Coplan ◽  
Barbara O. Rothbaum ◽  
...  

2008 ◽  
Vol 25 (6) ◽  
pp. 467-476 ◽  
Author(s):  
Mark H. Pollack ◽  
Michael W. Otto ◽  
Peter P. Roy-Byrne ◽  
Jeremy D. Coplan ◽  
Barbara O. Rothbaum ◽  
...  

2019 ◽  
Vol 101 ◽  
pp. 106564
Author(s):  
Meir Bialer ◽  
Helen Cross ◽  
Ulrike B.S. Hedrich ◽  
Lieven Lagae ◽  
Holger Lerche ◽  
...  

2020 ◽  
Vol 172 ◽  
pp. 107704 ◽  
Author(s):  
Stephen J. Kaar ◽  
Sridhar Natesan ◽  
Robert McCutcheon ◽  
Oliver D. Howes

2019 ◽  
Author(s):  
Fanny Grillet ◽  
Abbas Jariani ◽  
Juul Overkamp ◽  
Lidia Daszkiewicz ◽  
Kuan Yan ◽  
...  

Author(s):  
Ramon Tasan ◽  
Nicolas Singewald

Anxiety tests and models in rodents are useful tools to reveal neurochemical, cellular, and molecular underpinnings of normal and pathological anxiety-related behaviors, as well as novel treatment targets. While anxiety models are generated by various approaches such as selective breeding, anxiety tests most commonly involve unconditioned approach avoidance tasks and conditioned learning paradigms, both characterized by inherent advantages and limitations, in particular their predictive value for specific anxiety disorders. To further improve the validity and translatability of preclinical anxiety testing, it is promising that some anxiety-relevant endophenotypes have now been investigated using similar tests in rodents and humans and that the involved neural pathways and mechanisms overlap considerably in both species.


2016 ◽  
Vol 57 (50) ◽  
pp. 23927-23939 ◽  
Author(s):  
Shruti P. Hinge ◽  
Manas S. Orpe ◽  
Kapil V. Sathe ◽  
Gaurav D. Tikhe ◽  
Nishantbhaskar S. Pandey ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document